Goldman Sachs Maintains Buy on Amgen, Raises Price Target to $536
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice TargetHot
Goldman Sachs analyst Salveen Richter maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $481 to $536.
Goldman Sachs analyst Salveen Richter maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $481 to $536.